CG MedTech Co

CG MedTech Co Capital Intensity

The Capital Intensity Ratio of CG MedTech Co (056090.KQ) as of Nov 19, 2026 is 243.30 %. In the previous year, Capital Intensity Ratio was 309.62 % — a change of -21.42% (lower).

Capital Intensity

243.30 %

YoY

-21.42%

Last updated:

Capital Intensity Ratio of CG MedTech Co is 2025 243.30 % . Capital Intensity Ratio of CG MedTech Co was 2024 309.62 % . It decreases by -21.42% lower compared to the previous year.

The CG MedTech Co Capital Intensity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Capital Intensity
Date
Capital Intensity
Jan 1, 2018
236.26 KRW
Jan 1, 2019
204.17 KRW
Jan 1, 2020
231.98 KRW
Jan 1, 2021
197.24 KRW
Jan 1, 2022
343.56 KRW
Jan 1, 2023
226.20 KRW
Jan 1, 2024
309.62 KRW
Jan 1, 2025
243.30 KRW
The CG MedTech Co Capital Intensity history
YEARCapital IntensityYoY
243.30 %-21.42%
309.62 %+36.88%
226.20 %-34.16%
343.56 %+74.18%
197.24 %-14.97%
231.98 %+13.62%
204.17 %-13.58%
236.26 %-60.28%
594.85 %+5.08%
566.09 %+6.72%
530.44 %+136.25%
224.53 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

CG MedTech Co Stock analysis

What does CG MedTech Co do? CG MedTech Co Ltd generates revenue through two primary business segments. The Medical Device Business segment produces and sells spinal fixation devices, micro-invasive medical devices for back pain treatment, fracture treatment devices, and bioabsorbable alloy implants. These products are sold to healthcare providers and hospitals within the orthopaedic surgical market. The Electric Energy Business segment manufactures and markets electricity meters and integrated calorimeters, targeting utility companies and energy management sectors. Both segments operate under the company's established brand presence in their respective industries. The company's revenue streams are derived from direct sales to end-users in the medical and energy sectors. Orthopaedic surgical implants and devices are purchased by hospitals and clinics specializing in orthopaedic care, while electricity meters and calorimeters are bought by utility providers for infrastructure deployment. The firm's product portfolio is designed to meet specific technical requirements within these specialized markets. CG MedTech Co Ltd's business model focuses on manufacturing high-precision medical devices and energy measurement equipment. The Medical Device Business segment serves the healthcare industry with products for spinal and fracture treatments, while the Electric Energy Business segment supports energy management through metering solutions. This dual-segment approach allows the company to serve two distinct but complementary industrial sectors. CG MedTech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about CG MedTech Co stock

Capital Intensity Ratio of CG MedTech Co is 243.30 % in 2025.

Capital Intensity Ratio of CG MedTech Co changed from 309.62 % to 243.30 %, representing a -21.42% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Capital Intensity Ratio CG MedTech Co since 2006 – with annual values, charts, and detailed analysis.

Capital intensity measures the amount of assets needed to generate each unit of revenue. Lower ratios indicate asset-light business models.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Capital Intensity Ratio's CG MedTech Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Capital Intensity Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Capital Intensity Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — CG MedTech Co

All Key Metrics — CG MedTech Co